Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

被引:0
|
作者
Christian Wolfrum
Matthew N Poy
Markus Stoffel
机构
[1] The Laboratory of Metabolic Diseases,
[2] The Rockefeller University,undefined
来源
Nature Medicine | 2005年 / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
High-density lipoproteins (HDLs) are considered antiatherogenic because they mediate reverse cholesterol transport from the periphery to the liver for excretion and degradation. Here we show that mice deficient in apolipoprotein M (apoM), a component of the HDL particle, accumulated cholesterol in large HDL particles (HDL1) while the conversion of HDL to preβ-HDL was impaired. Accordingly, apoM-deficient mice lacked preβ-HDL, a subclass of lipid-poor apolipoproteins that serves as a key acceptor of peripheral cellular cholesterol. This deficiency led to a markedly reduced cholesterol efflux from macrophages to apoM-deficient HDL compared to normal HDL in vitro. Overexpression of apoM in Ldlr−/− mice protected against atherosclerosis when the mice were challenged with a cholesterol-enriched diet, showing that apoM is important for the formation of preβ-HDL and cholesterol efflux to HDL, and thereby inhibits formation of atherosclerotic lesions.
引用
收藏
页码:418 / 422
页数:4
相关论文
共 50 条
  • [1] Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
    Wolfrum, C
    Poy, MN
    Stoffel, M
    NATURE MEDICINE, 2005, 11 (04) : 418 - 422
  • [2] HUMAN APOLIPOPROTEIN A-I IN TRANSGENIC MICE RAISES HDL AND PROTECTS AGAINST ATHEROSCLEROSIS
    RUBIN, EM
    KRAUSS, RM
    SPANGLER, EA
    VERSTUYFT, JG
    CLIFT, SM
    CLINICAL RESEARCH, 1991, 39 (02): : A251 - A251
  • [3] Lipid efflux factors are required for the regression of atherosclerosis independent of non-HDL cholesterol levels
    Feig, Jonathan E.
    Mick, Stephanie L.
    Shamir, Raanan
    Parathath, Saj
    Joaquin, Victor A.
    Thorngate, Fayanne E.
    Fisher, Edward A.
    CIRCULATION, 2007, 116 (16) : 298 - 298
  • [4] HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis
    Tall, Alan R.
    Yvan-Charvet, Laurent
    Terasaka, Naoki
    Pagler, Tamara
    Wang, Nan
    CELL METABOLISM, 2008, 7 (05) : 365 - 375
  • [5] HDL cholesterol and atherosclerosis
    Mazzone, Theodore
    LANCET, 2007, 370 (9582): : 107 - 108
  • [6] Cellular cholesterol efflux and HDL
    Yokoyama, S
    SEIKAGAKU, 1998, 70 (11): : 1354 - 1359
  • [7] Cholesterol efflux and HDL function
    Parhofer, K.
    KARDIOLOGE, 2012, 6 (04): : 329 - 336
  • [8] HDL cholesterol efflux capacity
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02): : 101 - 101
  • [9] HDL and cellular cholesterol efflux
    Phillips, MC
    Rothblat, GH
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 114 - 114
  • [10] Preβ1-HDL -: Biogenesis and role in cholesterol efflux
    Sviridov, D
    Kingwell, B
    Hoang, A
    Dart, A
    Nestel, P
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (5-6) : A3 - A4